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Abstract
OBJECTIVES: Neonates with hypoplastic left heart syndrome (HLHS) are at risk of high mortality and neurodevelopmental morbidity. As
an alternative to Norwood-type stage I palliation, the hybrid procedure has been developed. It consists of bilateral pulmonary artery
banding, catheter-based stenting of the arterial duct and balloon atrioseptostomy and delays open-heart surgery. Thus, it may be asso-
ciated with a better outcome. The aim of this study was to determine the mortality and neurodevelopmental outcome in patients with
HLHS and other univentricular heart (UVH) defects treated with hybrid or Norwood procedures.
METHODS: Thirty-one children (18 males) with HLHS and other UVH defects undergoing Norwood or hybrid procedure between
2004 and 2008 were consecutively enrolled. Mortality and neurodevelopmental outcome at 1 year of age were determined.
RESULTS: One-year mortality was 36% (31% in the hybrid vs. 39% in the Norwood group, P = 0.71). Predictors of mortality were lower
birth weight (P = 0.02), older age at ﬁrst procedure (P = 0.02) and smaller size of ascending aorta (P = 0.05). Overall, median psycho-
motor development index (PDI) and mental development index (MDI) of the Bayley Scales of Infant Development II were lower than
the norm of 100 [PDI 57 (49–99), P < 0.001; MDI 91 (65–109), P = 0.002]. No effect of surgical treatment on neurodevelopmental
outcome was found. Predictors of impaired motor outcome were length of hospital stay (LOHS) (P = 0.01), lower body weight at second
procedure (P = 0.004) and female sex (P = 0.01). Predictors of impaired cognitive outcome were longer mechanical ventilation time (P =
0.03), intensive care unit stay (P = 0.04) and LOHS (P < 0.001), respectively.
CONCLUSIONS: Mortality at 1 year of age is comparable between patients undergoing hybrid and Norwood procedures. Early neuro-
developmental outcome is signiﬁcantly impaired in patients with both HLHS and other UVH defects. Multicentre randomized studies
are needed to determine the long-term neurodevelopmental outcome of children treated with the hybrid procedure.
Keywords: Congenital heart defects • Hypoplastic left heart syndrome • Norwood operation • Cardiopulmonary bypass •
Neurocognitive deﬁcits • Hybrid procedure
INTRODUCTION
Norwood-type stage I–III palliation constitutes the standard of
care in the majority of patients with hypoplastic left heart syn-
drome (HLHS) and other functionally univentricular heart (UVH)
defects associated with systemic outﬂow tract obstructions with
aortic arch hypoplasia and coarctation [1, 2]. Advances in the
peri- and intraoperative management have decreased surgical as
well as interstage mortality [3, 4]. Nevertheless, these patients are
still at particular risk for neonatal morbidity, including brain
injury and subsequent neurodevelopmental sequelae [5, 6].
The hybrid procedure has been developed as an alternative to
Norwood-type stage I palliation combining catheter-based and
surgical techniques [7, 8]. Bilateral pulmonary artery banding to-
gether with catheter-based stenting of the arterial duct and
balloon atrioseptostomy controls pulmonary blood ﬂow and pro-
vides a reliable systemic cardiac output through the patent arter-
ial duct as well as an unrestricted interatrial blood ﬂow [9]. Thus,
the hybrid procedure delays cardiopulmonary bypass to the age
of 3–5 months, at which age the comprehensive stage I and II
procedure can be performed. This may lead to a reduction in
neonatal and neurodevelopmental morbidity and mortality.
Therefore, we analysed the mortality as well as the neurodeve-
lopmental outcome at 1 year of age in patients with HLHS and
UVH defects treated with the hybrid and Norwood procedures
in a prospectively enrolled cohort.
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MATERIALS AND METHODS
Study design
This study is part of a prospective longitudinal clinical cohort
study on neurodevelopmental outcome and quality of life of
children operated for congenital heart disease (CHD). The study
has been approved by the Institutional Review Board of the
University Children’s Hospital Zurich, and written informed
consent has been obtained from the parents or legal guardians.
Patient population
All consecutive patients born between April 2004 and July 2008
with the diagnosis of HLHS and UVH were eligible. Patients’ in-
clusion criteria were main cardiac diagnosis of HLHS and other
UVH combined with systemic outﬂow tract obstruction including
aortic arch hypoplasia with severe aortic coarctation undergoing
open-heart surgery with Norwood-type stage I palliation or
hybrid procedure at our centre.
The decision on the preferred treatment strategy was made
patient-per-patient in an interdisciplinary conference incorporat-
ing the complete treatment team with paediatric cardiology,
cardiac surgery, intensive care medicine and anaesthesia. The
treatment strategy was afterwards presented to the parents for
their ﬁnal agreement. In our institution, exclusion criteria for the
hybrid procedure were severe aortic coarctation, hypoplasia of
the transverse aortic arch and the ascending aorta (deﬁned by a
minimum size of the ascending aorta <2 mm) as well as restrict-
ive foramen ovale and restricted pulmonary vein drainage.
Hybrid procedure
All procedures were performed under general anaesthesia. After
induction of anaesthesia, median sternotomy was performed,
and pulmonary arteries were banded bilaterally with a 3 mm
long Goretex tube (body weight <3 kg, 3 mm diameter tube and
body weight >3 kg, 3.5 mm diameter tube). The tube was length-
wise incised, wrapped around the left and right pulmonary arter-
ies and secured with interrupted sutures [8]. For the
catheter-based intervention, a 5 Fr sheath was placed and ﬁxed
in the lateral wall of the right atrium by the surgeon.
Self-expanding bare metal stents (Sinus Repo, Optimed Co.,
Ettlingen, Germany) were used for the arterial duct stenting, seri-
ally covering the complete duct backwards from the descending
aorta to the pulmonary artery under ﬂuoroscopic guidance. The
diameter of the stents was chosen at least 1 mm larger than the
size of the descending aorta. Atrial septal defects were dilated
using a 12 mm diameter Tyshak balloon dilatation catheter
(Numed, Inc., Hopkinton, NY, USA). In two patients, HLHS was
combined with only moderate aortic coarctation and consecu-
tive mild restriction of aortic backﬂow, not fulﬁlling exclusion cri-
teria for hybrid procedure; therefore, the aorta was stented
during hybrid procedure using balloon expandable stents
(Palmaz Blue, Cordis Co., Johnson & Johnson, Miami, FL, USA). A
modiﬁed right-sided Blalock–Taussig (BT) reverse shunt was in-
stalled between main pulmonary artery and brachiocephalic
trunk during the hybrid procedure in one patient with double
inlet left ventricle (DILV) and severe hypoplasia of the aortic
arch. In one patient with prenatally diagnosed HLHS and restrict-
ive foramen ovale, atrioseptectomy was performed at the ﬁrst
day of life under cardiopulmonary bypass together with bilateral
banding of the pulmonary arteries. The patient was then trans-
ferred to the catheterization laboratory for duct stenting.
Surgical management
Norwood-type stage I palliation. After median sternotomy in
general anaesthesia, the surgeon performed a Damus–Kaye–Stansel
anastomosis and a right-modiﬁed BT shunt or a right ventricle-to-
pulmonary artery shunt. The aortic arch was reconstructed with
xenopericard, and atrioseptectomy was performed under
hypothermic cardiopulmonary bypass with selective cerebral
perfusion. In eight patients, a 3.5 mm right-modiﬁed BT shunt was
performed, and eight patients received a 5 mm and two patients a
6 mm right ventricle-to-pulmonary artery shunt.
Norwood-type stage II palliation. Twelve patients
underwent Norwood-type stage II palliation at an age of 3–5
months. The shunt was resected, and bidirectional
cavopulmonary anastomosis was performed under moderate
hypo- or normothermic cardiopulmonary bypass in general
anaesthesia. If necessary, the aortic arch and/or the pulmonary
arteries were enlarged.
Comprehensive stage I and II palliation. In the case of
preceding hybrid procedure in the neonatal period,
comprehensive stage I and II palliation was performed at
approximately 3–5 months of age in 10 patients. This procedure
combines classical Norwood-type stage I and II procedures.
Therefore, after median sternotomy, under general anaesthesia,
the pulmonary artery bandings and the ductal stent/s were
removed, and thereafter, Damus–Kaye–Stansel anastomosis
together with aortic arch reconstruction and cavopulmonary
anastomosis and patch enlargement of the pulmonary arteries
and atrioseptectomy were performed under hypothermic
cardiopulmonary bypass.
Cardiopulmonary bypass
For cardiopulmonary bypass, we used alpha-stat blood gas manage-
ment and a pump ﬂow rate at 100–150 ml/kg/min to achieve a
mean arterial pressure of 40–50 mmHg. Norwood-type stage I palli-
ation and comprehensive stage I and II procedures were performed
under moderate hypothermia (nasopharyngeal temperature 22–28°
C). Norwood-type stage II palliation was performed either under
moderate hypothermia or under nearly normothermia (nasopha-
ryngeal temperature 32–35°C). We performed regional cerebral
perfusion with a pump ﬂow rate maintained at 30–50 ml/kg/min
and a target arterial pressure around 50–60 mmHg, measured in
the right radial artery. Modiﬁed ultraﬁltration at the end of cardio-
pulmonary bypass was performed in all patients.
Neurodevelopmental outcome
A standardized neuromotor examination was performed by an
experienced neurodevelopmental paediatrician (B.L.) before the
second procedure and at the age of 1 year. The assessment was
modiﬁed after Prechtl [10] and included a neuromotor score
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(NMS) (range 0–18, 0 was deﬁned as normal and 18 as severely
abnormal). All clinical examinations were performed under
stable haemodynamic conditions, and children were not venti-
lated. Additionally, at the age of 1 year, children were examined
with the Bayley Scales of Infant Development II [11]. This test
provides a psychomotor development index (PDI) and a mental
development index (MDI).
Statistical analysis
Analyses were performed using SPSS 16 (SPSS Inc., Chicago, IL,
USA). Pre-, intra- and postoperative variables were related to
mortality and outcome parameters (NMS, MDI and PDI) using
Mann–Whitney U-test for continuous variables and Fisher’s exact
test for dichotomous variables. For the comparison of scores
with the norm, we applied a one-sample t-test. To compare the
change in NMSs between 3 months and 1 year, the Wilcoxon
signed-rank test was applied. A P-value of less than 0.05 was
considered statistically signiﬁcant.
RESULTS
Patient population
Thirty-seven patients (21 males) with HLHS and other UVH
defects were eligible. Of these, six children were not surgically
treated either because they died before surgery (n = 3) or they
underwent comfort care (n = 3). Of the remaining 31 patients
(18 males), 18 were treated with Norwood and 13 with hybrid
procedure. Cardiac diagnoses included classical HLHS (n = 24),
unbalanced atrioventricular septal defect (AVSD) with left ven-
tricular hypoplasia (n = 1), double outlet right ventricle (DORV)
with left ventricular hypoplasia (n = 2) and DILV (n = 4). Patients
with DORV or unbalanced AVSD underwent hybrid procedure.
Two patients with DILV were operated by the Norwood proced-
ure and two by hybrid procedure. No genetic or malformation
syndrome was present in the included patients. After birth, all
patients received prostaglandin E2 infusion. Before surgery,
patients were spontaneously breathing (n = 28, 90%) or intubated
(n = 3, 10%). Reasons for intubation after birth were transfer to
our hospital in one patient (extubated before Norwood I) and
cardiogenic shock due to missed prenatal diagnosis in two
patients who died early after their ﬁrst surgical procedure (one
underwent Norwood stage I and one hybrid procedure). The
patient characteristics and perinatal and perioperative variables
are presented in Table 1, and details of surgical and anatomical
characteristics and neurodevelopmental outcome at 1 year of
age are presented in Table 2.
One-year mortality
Overall, 11 patients died before the age of 1 year. Patients died
early (<30 days, n = 5), late (>30 days, n = 3) after surgery or at
home during interstage (n = 3). One patient died during late
postoperative course of septicaemia due to an accidental
Table 1: Comparison of perinatal and perioperative variables for patients undergoing hybrid and Norwood procedures
Patients, n = 31 Norwood group Hybrid group P-valuea Survivors Deceased
18 13 20 11
Male/female 10/8 8/5 1.0 14/6 4/7
Apgar 5 min 9 (7–10) 9 (8–9) 0.37 9 (8–10) 9 (7–9)
Prenatal diagnosis 9 (50%) 9 (69%) 0.46 13 (65%) 5 (45%)
Gestational age (weeks) 38 (35–40) 38 (38–41) 0.19 38 (37–41) 38 (35–40)
Birth weight (kg) 3.1 (2.1–4.2) 2.9 (2.2–3.9) 0.23 3.2 (2.4–4.2) 2.8 (2.1–3.8)
Birth head circumference (cm) 34.5 (30–37) 34 (30.5–36.2) 0.47 34 (32–36) 32.3 (30–37)
Antegrade flow in ascending aorta at birth 5 (28%) 7 (58%) 0.14 9 (47%) 3 (27%)
Diameter of the ascending aorta (mm) 3.0 (1.9–6.7) 4.3 (2.7–6.5) 0.05 4.7 (1.9–6.7) 3.5 (2–4.6)
Cardiac diagnosis: HLHS/othersb 16/2 8/5 0.10 15/5 9/2
Age at first procedure (days) 5.5 (2–52) 5 (0–7) 0.23 4 (0–52) 7 (3–11)
Body weight at first procedure (kg) 3.2 (2.1–4.1) 3.0 (2.2–3.9) 0.33 3.2 (2.6–4.1) 2.9 (2.1–4.1)
Bypass time (min) during first procedure 191 (140–325) – – –
Aortic clamp time (min) during first procedure 122 (35–157) – – –
Mechanical ventilation (days) after first procedure 5 (2–26) 3 (1–11) 0.15 4 (1–15) 6 (2–26)
Length of ICU stay (days) after first procedure 11 (5–39) 8 (2–15) 0.12 10 (2–39) 11 (6–31)
Length of hospital stay (days) after first procedure 31 (15–90) 35 (13–204) 0.31 32 (13–204) 32 (30–34)
Age at second procedure (days) 131 (64–180) 130 (44–162) 0.57 132 (64–180) 83 (44–135)
Body weight at second procedure (kg) 5.2 (3.6–7.0) 5.4 (2.7–7.1) 0.88 5.4 (3.6–7.1) 4.1 (2.7–5.3)
Bypass time (min) during second procedure 111 (65–283) 242 (143–373) 0.01 225 (65–285) 143 (75–373)
Aortic clamp time (min) during second procedure 107 (72–141) 143 (83–194) 0.31 91 (0–194) 83 (0–194)
Mechanical ventilation (days) after second procedure 1.5 (0–6) 2 (0–24) 0.52 1 (0–6) –
Length of ICU stay (days) after second procedure 5 (2–14) 5 (2–29) 0.45 5 (2–16) –
Length of hospital stay (days) after second procedure 14.5 (11–46) 30 (12–49) 0.06 18 (11–49) –
Results are presented as median and ranges or in number and percent.
aMann–Whitney U-test for continuous variables and χ2 with Fisher’s exact test for dichotomous variables.
bOther cardiac diagnoses are DILV in four, DORV in two and unbalanced AVSD in one patient.
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intestinal perforation during change of percutaneous endoscopic
gastrostomy tube. Another patient died of ongoing myocardial
failure despite early Fontan procedure to reduce ventricular
volume overload at the age of 10 months. One-year mortality
was 36% (31% in the hybrid group vs. 39% in the Norwood
group, P = 0.71). Of the 20 surviving patients (HLHS n = 15 and
Table 2: Overview of surgical and anatomical characteristics and 1-year outcome of surviving patients after hybrid and
Norwood procedures
Patient Procedure Cardiac diagnosis, size of ascending
aorta, flow in ascending aorta
Risk factors Reinterventions PDI MDI
1 Norwood HLHS: AA/MA, 2.7 mm, anterograde
flow
None 50 66
2 Norwood HLHS: AS/MA, 4.0 mm, retrograde
flow
None 57 102
3 Norwood HLHS: AA/MA, not available,
retrograde flow
Restrictive
foramen ovale
First balloon dilatation and stenting re-CoA na 105
Second re-balloon dilatation of stent in CoA
Third surgical removal of stent, patch
enlargement CoA
4 Norwood HLHS: AA/MA, 2.5 mm, retrograde
flow
None 77 96
5 Norwood HLHS: AA/MA, 6.0 mm, retrograde
flow
First stenting LPA stenosis 50 65
Second restenting LPA stenosis (after stent
removal during Norwood II)
Third balloon dilatation LPA stent
6 Norwood HLHS: AS/MS, 5.0 mm, anterograde
flow
Restrictive
foramen ovale
None 72 93
7 Hybrid HLHS: AA/MS, 6.3 mm, retrograde
flow
Restrictive
foramen ovale
First stenting restrictive foramen ovale 53 74
Second surgical rebanding LPA and RPA
8 Hybrid HLHS: AA/MS, 4.0 mm, retrograde
flow
First stenting PDA restenosis, stenting CoA 73 84
Second dilatation restrictive ASD
Third surgical patch enlargement RPA and
LPA stenosis
9 Hybrid + stent in
CoA
HLHS: AS/MA, 5.0 mm, anterograde
flow
First balloon dilatation of RPA and LPA
stenosis
65 88
10 Hybrid + septectomy
with CPB
HLHS: AS/MA, 4.3 mm, retrograde
flow
Restrictive
foramen ovale
First surgical loosening PA bandings 86 94
Second coiling MAPCA
11 Hybrid HLHS: AS/MS, 6.5 mm, anterograde
flow
First stenting restrictive ASD 90 97
Second stenting LPA stenosis, coiling
venovenous collateral
12 Norwood DILV, D-TGA, VSD, IAA-B, 5.5 mm,
anterograde flow
First balloon dilatation residual CoA 81 109
13 Hybrid DILV, L-TGA, 2.5 mm, anterograde
flow
First stenting LPA stenosis 99 102
14 Norwood HLHS: AS/MS, 6.0 mm, retrograde
flow
Restrictive
foramen ovale
None 56 82
15 Hybrid DORV, VSD, hypoplastic LV, 6.0 mm,
anterograde flow
None 54 96
16 Hybrid HLHS: AA/MS, 2.8 mm, retrograde
flow
First balloon dilatation restrictive ASD 57 86
17 Norwood HLHS: AA/MA, <2 mm, retrograde
flow
First balloon dilatation CoA <50 78
18 Hybrid+BT-shunt DILV, D-TGA, 6.3 mm, anterograde
flow
First balloon dilatation right PA banding 50 71
Second coiling venovenous collateral,
stenting left PA stenosis, coiling MAPCAs
19 Norwood DILV, L-TGA, 6.7 mm, anterograde
flow
Restrictive
foramen ovale
None 57 99
20 Norwood HLHS: AA/MA, <2 mm, retrograde
flow
None <50 70
AA: aortic atresia; AS: aortic stenosis; ASD: atrial septal defect; CoA: aortic coarctation; CPB: cardiopulmonary bypass; d-TGA: dextro-transposition of the
great arteries; IAA: interrupted aortic arch; LPA: left pulmonary artery; L-TGA: levo-transposition of the great arteries; LV: left ventricle; MA: mitral atresia;
MAPCA: major aortopulmonary collateral artery; MS: mitral stenosis; na: not assessed; PA: pulmonary artery; PDA: patent ductus arteriosus; RPA: right
pulmonary artery; VSD: ventricular septal defect.
W. Knirsch et al. / European Journal of Cardio-Thoracic Surgery36
UVH n = 5), 11 underwent Norwood stage I and 9 hybrid
procedure.
Perioperative morbidity during ﬁrst year of life
The duration of the combined bypass times after hybrid and
comprehensive stage I and II, and Norwood-type stage I and II
palliation, respectively, was shorter in the hybrid group with 250
(143–373) min than in the Norwood group with 293 (205–466)
min (P = 0.06). Combined mechanical ventilation times were also
shorter in the hybrid group with 6 (1–28) days vs. 8 (2–17) days
(P = 0.70) as well as the median duration of intensive care unit
(ICU) stays after both procedures with 16 (6–35) days in the
hybrid group vs. 19 (8–43) days in the Norwood group (P = 0.56).
Median combined length of hospital stays (LOHS) did not differ
between the two treatment groups. One patient in the hybrid
group stayed 204 days in hospital; he could not be discharged
due to complex psycho-social problems. Patients undergoing
Norwood procedure had less reinterventions (surgery and inter-
ventional heart catheterization) during the ﬁrst year of life than
those who underwent hybrid procedure [median: 0 (0–4) in the
Norwood group vs. 2 (0–8) in the hybrid group; P = 0.001].
Neurodevelopmental outcome at 3 months and 1
year of age
At a median age of 3 (range 1–6) months, before the second
procedure, 19 children were examined. Median NMS was com-
parable between the Norwood group and the hybrid group [4
(1–10) vs. 4 (1–9); P = 0.64]. At a median age of 12 (range 10–15)
months, all 20 surviving children were examined. NMS for both
groups improved (P = 0.03) between 3 and 12 months of age,
and at 1 year, median NMSs were similar between Norwood
and hybrid groups (Fig. 1).
At 1 year of age, median MDI for both groups was 91 (range
65–109), signiﬁcantly lower than the norm (P = 0.002), but com-
parable between both treatment groups [Norwood 93 (65–109)
vs. hybrid 88 (71–102), P = 1.0] (Fig. 2). Only children in the
Norwood group had an MDI below 70 [Norwood n = 2 (18%) vs.
hybrid n = 0 (0%), P = 0.5].
Median PDI was 57 (range 49–99), signiﬁcantly lower than the
norm (P < 0.001). Median PDI was slightly lower, but not signiﬁ-
cantly in the Norwood group compared with the hybrid group
[Norwood 56.5 (49–81) vs. hybrid 65 (50–99), P = 0.18] (Fig. 3).
The rate of children with a PDI below 70 was similar in both
groups [Norwood n = 7 (64%) vs. hybrid n = 5 (56%), P = 0.60].
We did not ﬁnd any signiﬁcant difference in the neurodeve-
lopmental outcome parameters (NMS, MDI and PDI) between
patients with HLHS and UVH nor between patients with univen-
tricular right ventricle (HLHS, DORV and unbalanced AVSD) and
univentricular left ventricle (DILV) (all P > 0.1).
The one patient who received a BT shunt during the hybrid
procedure had an MDI of 71 and a PDI of 50. The other patient
with HLHS and restrictive foramen ovale who underwent cardio-
pulmonary bypass to perform atrioseptectomy together with
hybrid procedure had an MDI of 94 and a PDI of 86.
Predictors of mortality
Lower birth weight (P = 0.02), older age at ﬁrst procedure (P =
0.02) and smaller size of the ascending aorta (P = 0.05) were pre-
dictors of mortality during ﬁrst year of life. All other perinatal
Figure 1: NMS at 1 year of age comparing hybrid and Norwood procedures.
Boxplots showing NMS at 1 year of age in patients with HLHS and other UVH
treated by the hybrid procedure (n = 9) and the Norwood procedure (n = 11),
P = 0.35.
Figure 2: MDI at 1 year of age comparing hybrid and Norwood procedures.
Boxplots showing MDI of the Bayley Scales of Infant Development II at 1 year
of age in patients with HLHS and other UVH treated by the hybrid procedure
(n = 9) and the Norwood procedure (n = 11), P = 1.0.
Figure 3: PDI at 1 year of age comparing hybrid and Norwood procedures.
Boxplots showing PDI of the Bayley Scales of Infant Development II at 1 year
of age in patients with HLHS and other UVH treated by the hybrid procedure
(n = 9) and the Norwood procedure (n = 11), P = 0.18.
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and perioperative parameters (Table 1) were not related to
1-year mortality.
Predictors of neurodevelopmental outcome at 1
year of age
The combined (after Norwood stage I and II and after hybrid
and comprehensive stage I and II procedures, respectively) dur-
ation of mechanical ventilation (P = 0.03), the combined length
of ICU stays (P = 0.04) as well as the combined LOHS (P < 0.001)
correlated inversely with MDI at 1 year of age. Antegrade ﬂow in
the ascending aorta at birth was associated with a higher MDI
(P = 0.02), but not with the PDI. The combined LOHS was in-
versely correlated with PDI (P = 0.01). Higher body weight at the
second procedure (P = 0.004) and male sex (P = 0.01) were asso-
ciated with higher PDI. There was a trend that a PDI below 70
was associated with a smaller head circumference at the time of
1-year follow-up (P = 0.06). The type (surgery or catheter inter-
vention) and the overall number of reinterventions during the
ﬁrst year of life did not correlate with neurodevelopmental out-
comes. All other perinatal and perioperative parameters
(Table 1) were not associated with MDI and PDI, and no variable
was associated with NMS.
DISCUSSION
HLHS and related forms of UVH have become surgically treat-
able with the Norwood procedure [12]. As an alternative treat-
ment option, the hybrid approach has been developed and
continuously optimized [7–9]. This procedure postpones cardio-
pulmonary bypass surgery beyond the critical neonatal period
with the aim to reduce mortality and to improve neurodevelop-
mental outcome. However, to the best of our knowledge, there
is no study comparing neurodevelopmental outcome between
patients treated with the hybrid or Norwood procedure.
In our study, cognitive as well as motor outcome at 1 year of
age was below the norm for all patients, and we did not ﬁnd an
effect of treatment strategy on outcome. Only motor outcome
was somewhat poorer in children undergoing Norwood proced-
ure compared with those undergoing hybrid procedure (PDI
56.5 vs. 65.0), but the difference was not signiﬁcant.
Independent of the treatment strategy, the rate of moderate
impairments was higher for the motor (60% PDI <70) than for
the cognitive outcome (10% MDI <70). This is consistent with
other studies [13] and may be due in part to the neurological ab-
normalities such as generalized hypotonia [14] or due to the lack
of motor development experience associated with prolonged
hospital stay [15]. The median MDI of 91 in our population was
in the normal range and conﬁrms the results of Tabbutt et al.
[16] (median MDI of 90) at 1 year of age in patients with HLHS
undergoing Norwood-type staged palliation. In contrast, motor
outcome in our patients was lower than that in the cohort of
Tabbutt et al. [16] (median PDI 57 compared to 73). This differ-
ence may be explained by the inclusion of a less severely
affected study population in their cohort. Further, the low PDI in
our study may be due to the fact that the reference norms for
the Bayley Scales of Infant Development are obtained from the
USA and may be different in other populations. This is supported
by a study performed in Australia where healthy term-born
children had a mean PDI of 88.3 at 1 year of age instead of the
reference norm of 100 [17].
Risk factors for adverse neurodevelopmental outcomes
included postoperative factors such as duration of mechanical
ventilation, duration of combined ICU stays and LOHS, predicting
poorer cognitive outcome, whereas poorer motor outcome was
predicted by the combined LOHS, female sex and lower weight
at the second procedure. These results conﬁrm those of previ-
ously published studies [18–20]. In our study, an antegrade aortic
ﬂow at birth was predictive of better cognitive outcomes. A
similar association has been shown for school-aged children
after Norwood procedure by Mahle et al. [18]. They showed that
children with an aortic valve atresia demonstrated lower math
achievement test scores after Norwood procedure or heart
transplantation for HLHS.
We also examined the mortality of our cohort. Overall, 1-year
mortality rate (36%) was high, but comparable to other popula-
tions treated with the Norwood procedure where it ranged
between 31 and 48% [3, 21]. In our study, mortality rate after
hybrid procedure (31%) was similar to that after Norwood pro-
cedure (39%), which conﬁrms a recently published study by
Pizarro et al. [22]. Predictors of mortality in our study included
smaller size of the ascending aorta and lower birth weight, con-
ﬁrming ﬁndings of the past decade [21, 22].
Study limitations are the small study population in a single-
centre setting without randomization of patients into treatment
groups, potentially resulting in a bias of healthier patients
treated with the hybrid procedure, although only the diameter
of the ascending aorta was different between both groups
before ﬁrst surgical procedure (Table 1). Furthermore, periopera-
tive intensive care management was not standardized, and
cardiac variables such as myocardial function or degree of
oxygen saturation were not systematically collected.
Neuromonitoring prior to surgery at the time of study was
limited to cerebral ultrasound and did not include routine cere-
bral magnetic imaging or cerebral function monitoring.
Based on the results of this study, it remains unclear whether
the hybrid procedure can reduce mortality and neurological
morbidity. Many aspects contribute to these two outcome para-
meters and need to be considered. Confounding factors include
medical risk factors and anatomical conditions. For example, the
larger diameter of the ascending aorta in the hybrid group may
reﬂect the inclusion of infants with a better cerebral perfusion,
existing already during intrauterine life, which per se might lead
to a better cognitive outcome. Possible disadvantages of the
hybrid procedure include the persistent abnormal cerebral
blood ﬂow and the need for more reinterventions such as
re-dilatation of the pulmonary arteries. Furthermore, later age at
surgery may be associated with a higher rate of acquired cere-
bral abnormalities [23]. Besides the anatomic factors and the
modiﬁable clinical care strategies, there is also evidence of con-
genitally acquired brain injury in term newborns with CHD due
to impaired early brain development already in utero as a result
of abnormalities in cerebral blood ﬂow [24]. Furthermore, it
remains to be proved whether once the learning curve for the
relatively new hybrid procedure has been completed, it might
contribute to a better outcome.
Thus, it remains of outmost importance to determine the
outcome of children treated with hybrid procedure in comparison
to that of the Norwood procedure to establish the best treatment
strategy for this most vulnerable population. This can only be
achieved by performing a large multicentre randomized trial, in
W. Knirsch et al. / European Journal of Cardio-Thoracic Surgery38
which the effect size can be based on the results of our study and
in which all potential risk factors such as preoperative delayed
brain development and brain injury, intra- and postoperative
factors and socio-demographic factors need to be considered.
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